{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:35:21Z","timestamp":1791110121070,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"vor","delay-in-days":315,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Brasileira de Psiquiatria"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.rbp.2012.07.002","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T15:05:08Z","timestamp":1361199908000},"page":"125-148","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S2","title":["New Molecular Targets for PET and SPECT Imaging in Neurodegenerative Diseases"],"prefix":"10.1016","volume":"34","author":[{"given":"Marcel","family":"Benadiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Luurtsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro","family":"Wichert-Ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Buchpigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo Busatto","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.rbp.2012.07.002_bib0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd2290","article-title":"Molecular imaging in drug development","volume":"7","author":"Willmann","year":"2008","journal-title":"Nat Rev Drug Discov."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1039\/B922628C","article-title":"Molecular tracers for the PET and SPECT imaging of disease","volume":"40","author":"Pimlott","year":"2011","journal-title":"Chem Soc Rev."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1046-2023(02)00085-3","article-title":"Positron emission tomography: imaging and quantification of neurotransporter availability","volume":"27","author":"Laruelle","year":"2002","journal-title":"Methods."},{"issue":"8","key":"10.1016\/j.rbp.2012.07.002_bib0020","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00259-009-1301-z","article-title":"Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease","volume":"37","author":"N\u00e5gren","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"7","key":"10.1016\/j.rbp.2012.07.002_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2174\/156652407782564462","article-title":"Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism","volume":"7","author":"Zhang Y-wu","year":"2007","journal-title":"Curr Mol Med."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol."},{"issue":"19","key":"10.1016\/j.rbp.2012.07.002_bib0035","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000260969.94695.56","article-title":"PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment","volume":"68","author":"Kemppainen","year":"2007","journal-title":"Neurology."},{"issue":"15","key":"10.1016\/j.rbp.2012.07.002_bib0040","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/WNL.0b013e3181bacf1b","article-title":"Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls","volume":"73","author":"Scheinin","year":"2009","journal-title":"Neurology."},{"issue":"Pt 5","key":"10.1016\/j.rbp.2012.07.002_bib0045","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain."},{"issue":"Pt 11","key":"10.1016\/j.rbp.2012.07.002_bib0050","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain."},{"issue":"20","key":"10.1016\/j.rbp.2012.07.002_bib0055","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00259-007-0523-1","article-title":"In vivo amyloid imaging with PET in frontotemporal dementia","volume":"35","author":"Engler","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.rbp.2012.07.002_bib0075","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","article-title":"PET imaging of amyloid deposition in patients with mild cognitive impairment","volume":"29","author":"Forsberg","year":"2008","journal-title":"Neurobiol aging."},{"issue":"10","key":"10.1016\/j.rbp.2012.07.002_bib0080","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology."},{"issue":"12","key":"10.1016\/j.rbp.2012.07.002_bib0085","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","article-title":"Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography","volume":"79","author":"Edison","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.rbp.2012.07.002_bib0090","doi-asserted-by":"crossref","unstructured":"Gomperts SN, Locascio JJ, Marquie M, Santarlasci AL, Rentz DM, Maye J, et al. Brain amyloid and cognition in Lewy body diseases. Mov disord [Available from: http:\/\/www.ncbi.nlm.nih. gov\/pubmed\/22693110]. 2012.[cited 2012 Jun 24].","DOI":"10.1002\/mds.25048"},{"issue":"39","key":"10.1016\/j.rbp.2012.07.002_bib0095","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1523\/JNEUROSCI.0630-07.2007","article-title":"In vitro characterization of Pittsburgh compound-B binding to Lewy bodies","volume":"27","author":"Fodero-Tavoletti","year":"2007","journal-title":"J Neurosci."},{"issue":"5","key":"10.1016\/j.rbp.2012.07.002_bib0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ana.21345","article-title":"Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease","volume":"63","author":"Kadir","year":"2008","journal-title":"Ann Neurol."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0105","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/jm901039z","article-title":"18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective","volume":"53","author":"Kung","year":"2010","journal-title":"J Med Chem."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann Neurol."},{"issue":"6","key":"10.1016\/j.rbp.2012.07.002_bib0115","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J Nucl Med."},{"issue":"Suppl 3","key":"10.1016\/j.rbp.2012.07.002_bib0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2011-0068","article-title":"Florbetaben to trace amyloid-\u03b2 in the Alzheimer brain by means of PET","volume":"26","author":"Barthel","year":"2011","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.rbp.2012.07.002_bib0125","unstructured":"FDA Approves 18F-Florbetapir PET Agent. J Nucl Med. 2012; 53(6):15N."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0130","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.bmcl.2010.11.096","article-title":"99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for \u03b2-amyloid plaques","volume":"21","author":"Cui","year":"2011","journal-title":"Bioorg Med Chem Lett."},{"issue":"5054","key":"10.1016\/j.rbp.2012.07.002_bib0135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science."},{"issue":"4","key":"10.1016\/j.rbp.2012.07.002_bib0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology."},{"issue":"3 Pt 1","key":"10.1016\/j.rbp.2012.07.002_bib0145","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease","volume":"41","author":"G\u00f3mez-Isla","year":"1997","journal-title":"Ann Neurol."},{"issue":"6","key":"10.1016\/j.rbp.2012.07.002_bib0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ana.410410618","article-title":"A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes","volume":"41","author":"G\u00f3mez-Isla","year":"1997","journal-title":"Ann Neurol."},{"issue":"338","key":"10.1016\/j.rbp.2012.07.002_bib0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1254\/jphs.11R08FM","article-title":"Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer's Disease: Novel PET\/SPECT Imaging Probes for Diagnosis of Alzheimer's Disease","volume":"344","author":"Ono","year":"2012","journal-title":"J Pharmacol Sci."},{"issue":"24","key":"10.1016\/j.rbp.2012.07.002_bib0165","doi-asserted-by":"crossref","first-page":"RC189","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","article-title":"Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease","volume":"21","author":"Agdeppa","year":"2001","journal-title":"J Neurosci."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","article-title":"Localization of neurofibrillary tangles and beta- amyloid plaques in the brains of living patients with Alzheimer disease","volume":"10","author":"Shoghi-Jadid","year":"2002","journal-title":"Am J Geriatr Psychiatry."},{"issue":"6","key":"10.1016\/j.rbp.2012.07.002_bib0175","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.febslet.2008.02.025","article-title":"Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3- hydroxycarbonyl-4-hydroxy)styrylbenzene]","volume":"582","author":"Velasco","year":"2008","journal-title":"FEBS lett."},{"issue":"4","key":"10.1016\/j.rbp.2012.07.002_bib0180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/NEN.0b013e3181d709eb","article-title":"Curcumin labeling of neuronal fibrillar tau inclusions in human brain samples","volume":"69","author":"Mohorko","year":"2010","journal-title":"J Neuropathol Exp Neurol."},{"issue":"25","key":"10.1016\/j.rbp.2012.07.002_bib0185","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","article-title":"PET of brain amyloid and tau in mild cognitive impairment","volume":"355","author":"Small","year":"2006","journal-title":"N Engl J Med."},{"issue":"8","key":"10.1016\/j.rbp.2012.07.002_bib0190","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nucmedbio.2008.09.002","article-title":"Peripheral metabolism of [(18)F]FDDNP and cerebral uptake of its labelled metabolites","volume":"35","author":"Luurtsema","year":"2008","journal-title":"Nucl Med Biol."},{"issue":"47","key":"10.1016\/j.rbp.2012.07.002_bib0195","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1523\/JNEUROSCI.1738-05.2005","article-title":"Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease","volume":"25","author":"Okamura","year":"2005","journal-title":"J Neurosci."},{"issue":"Pt 4","key":"10.1016\/j.rbp.2012.07.002_bib0200","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awr038","article-title":"18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease","volume":"134","author":"Fodero-Tavoletti","year":"2011","journal-title":"Brain."},{"issue":"13","key":"10.1016\/j.rbp.2012.07.002_bib0205","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/j.bmcl.2010.05.027","article-title":"Development of dual functional SPECT\/fluorescent probes for imaging cerebral beta-amyloid plaques","volume":"20","author":"Ono","year":"2010","journal-title":"Bioorg Med Chem Lett."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nbd.2007.07.018","article-title":"Differentiating Alzheimer disease-associated aggregates with small molecules","volume":"28","author":"Honson","year":"2007","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.rbp.2012.07.002_bib0215","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1100\/2011\/371893","article-title":"Interaction between \u03b1-synuclein and other proteins in neurodegenerative disorders","volume":"11","author":"Jellinger","year":"2011","journal-title":"ScientificWorldJournal."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2009.02.056","article-title":"alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity","volume":"454","author":"Liu","year":"2009","journal-title":"Neurosci lett."},{"key":"10.1016\/j.rbp.2012.07.002_bib0225","doi-asserted-by":"crossref","unstructured":"Bellucci A, Zaltieri M, Navarria L, Grigoletto J, Missale C, Spano P. From \u03b1-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease. Brain Res [Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22560500]. 2012.[cited 2012 Jun 25].","DOI":"10.1016\/j.brainres.2012.04.014"},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0230","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1074\/jbc.M102981200","article-title":"Tubulin seeds alpha-synuclein fibril formation","volume":"277","author":"Alim","year":"2002","journal-title":"J Biol Chem."},{"issue":"4","key":"10.1016\/j.rbp.2012.07.002_bib0235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-2004-6412","article-title":"Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein","volume":"6","author":"Alim","year":"2004","journal-title":"J Alzheimers Dis."},{"issue":"5785","key":"10.1016\/j.rbp.2012.07.002_bib0240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","article-title":"Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation","volume":"103","author":"Uversky","year":"2007","journal-title":"J Neurochem."},{"issue":"4","key":"10.1016\/j.rbp.2012.07.002_bib0250","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2967\/jnumed.106.037556","article-title":"2-(2-[2-Dimethylaminothiazol-5-yl] ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients","volume":"48","author":"Kudo","year":"2007","journal-title":"J Nucl Med."},{"issue":"1\u20133","key":"10.1016\/j.rbp.2012.07.002_bib0255","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.06.042","article-title":"In vitro characterisation of BF227 binding to alpha-synuclein\/Lewy bodies","volume":"617","author":"Fodero-Tavoletti","year":"2009","journal-title":"Eur J Pharmacol."},{"issue":"Pt 6","key":"10.1016\/j.rbp.2012.07.002_bib0260","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/brain\/awq091","article-title":"In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol- 5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy","volume":"133","author":"Kikuchi","year":"2010","journal-title":"Brain."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0265","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/157488711796575577","article-title":"Neuroinflammation and ageing: current theories and an overview of the data","volume":"6","author":"Pizza","year":"2011","journal-title":"Rev Recent Clin Trials."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.12.004","article-title":"Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair","volume":"118","author":"Chen","year":"2008","journal-title":"Pharmacol Ther."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.002_bib0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann Neurol."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.002_bib0280","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00259-010-1612-0","article-title":"In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease","volume":"38","author":"Yokokura","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"9280","key":"10.1016\/j.rbp.2012.07.002_bib0285","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","article-title":"In-vivo measurement of activated microglia in dementia","volume":"358","author":"Cagnin","year":"2001","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.rbp.2012.07.002_bib0290","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ana.20332","article-title":"In vivo detection of microglial activation in frontotemporal dementia","volume":"56","author":"Cagnin","year":"2004","journal-title":"Ann Neurol."},{"issue":"33","key":"10.1016\/j.rbp.2012.07.002_bib0295","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J Neurosci."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.002_bib0300","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11481-008-9142-2","article-title":"Imaging microglial activation during neuroinflammation and Alzheimer's disease","volume":"4","author":"Venneti","year":"2009","journal-title":"J Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13244-011-0128-x","article-title":"Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases","volume":"3","author":"Ching","year":"2011","journal-title":"Insights Imaging."},{"issue":"6","key":"10.1016\/j.rbp.2012.07.002_bib0310","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11307-009-0211-6","article-title":"[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis","volume":"11","author":"Doorduin","year":"2009","journal-title":"Mol Imaging Biol."},{"issue":"4","key":"10.1016\/j.rbp.2012.07.002_bib0315","first-page":"573","article-title":"11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation","volume":"48","author":"Boutin","year":"2007","journal-title":"JNuclMed."},{"issue":"5","key":"10.1016\/j.rbp.2012.07.002_bib0320","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00259-009-1353-0","article-title":"In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111 [(11)C]CLINME and [(11)C] PK11195 in an acute rodent model","volume":"37","author":"Van Camp","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"17","key":"10.1016\/j.rbp.2012.07.002_bib0325","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1523\/JNEUROSCI.2900-11.2012","article-title":"Imaging Microglial\/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714","volume":"32","author":"Abourbeh","year":"2012","journal-title":"J Neurosci."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.002_bib0330","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2967\/jnumed.111.095653","article-title":"Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7- dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide","volume":"53","author":"Tang","year":"2012","journal-title":"J Nucl Med."},{"issue":"5","key":"10.1016\/j.rbp.2012.07.002_bib0335","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-011-2041-4","article-title":"The translocator protein ligand [(18)F]DPA-714 images glioma and activated microglia in vivo","volume":"39","author":"Winkeler","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0340","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2967\/jnumed.111.096388","article-title":"18F-FEAnGA for PET of \u03b2-glucuronidase activity in neuroinflammation","volume":"53","author":"Antunes","year":"2012","journal-title":"J Nucl Med."},{"key":"10.1016\/j.rbp.2012.07.002_bib0345","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1749-6632.1999.tb09388.x","article-title":"Imidazoline receptors and human brain disorders","volume":"881","author":"Garc\u00eda-Sevilla","year":"1999","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.rbp.2012.07.002_bib0350","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.1999.tb09350.x","article-title":"Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands","volume":"881","author":"Lalies","year":"1999","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuint.2010.10.013","article-title":"Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography","volume":"58","author":"Guly\u00e1s","year":"2011","journal-title":"Neurochem Int."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.002_bib0360","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nucmedbio.2011.07.008","article-title":"PET study using [11C]FTIMD with ultra-high specific activity to evaluate I2-imidazoline receptors binding in rat brains","volume":"39","author":"Kawamura","year":"2012","journal-title":"Nucl Med Biol."},{"issue":"6","key":"10.1016\/j.rbp.2012.07.002_bib0365","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/syn.21541","article-title":"Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl- 1H-indole), for the imidazoline binding site","volume":"66","author":"Tyacke","year":"2012","journal-title":"Synapse."},{"issue":"7","key":"10.1016\/j.rbp.2012.07.002_bib0370","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2967\/jnumed.110.084046","article-title":"In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester","volume":"52","author":"Shukuri","year":"2011","journal-title":"J Nucl Med."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0375","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2967\/jnumed.110.087031","article-title":"Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG","volume":"53","author":"Carter","year":"2012","journal-title":"J Nucl Med."},{"issue":"12","key":"10.1016\/j.rbp.2012.07.002_bib0380","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1007\/s00259-011-1895-9","article-title":"In vivo imaging of astrocytosis in Alzheimer's disease: an 11C-L-deuteriodeprenyl and PIB PET study","volume":"38","author":"Santillo","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0385","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000070857","article-title":"Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study","volume":"50","author":"Versijpt","year":"2003","journal-title":"Eur Neurol."},{"issue":"12","key":"10.1016\/j.rbp.2012.07.002_bib0390","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s00259-008-0834-x","article-title":"Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation","volume":"35","author":"Arlicot","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"8","key":"10.1016\/j.rbp.2012.07.002_bib0395","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1007\/s00259-011-1784-2","article-title":"Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation","volume":"38","author":"Mattner","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0400","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbrc.2009.08.102","article-title":"Synthesis of [(125)I]iodoDPA-713: a new probe for imaging inflammation","volume":"389","author":"Wang","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"10.1016\/j.rbp.2012.07.002_bib0405","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1194\/jlr.D800056-JLR200","article-title":"Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats","volume":"50","author":"Gao","year":"2009","journal-title":"J Lipid Res."},{"issue":"12","key":"10.1016\/j.rbp.2012.07.002_bib0410","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/jn\/138.12.2515","article-title":"Arachidonic acid and the brain","volume":"138","author":"Rapoport","year":"2008","journal-title":"J Nutr."},{"issue":"4","key":"10.1016\/j.rbp.2012.07.002_bib0415","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3945\/jn.109.114884","volume":"140","author":"Zhang","year":"2010","journal-title":"J Nutr"},{"issue":"9","key":"10.1016\/j.rbp.2012.07.002_bib0420","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00702-011-0619-4","article-title":"Inhibition of phospholipase A(2) in rat brain decreases the levels of total Tau protein","volume":"118","author":"Schaeffer","year":"2011","journal-title":"J Neural Transm."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.002_bib0425","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12035-011-8200-6","article-title":"Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity","volume":"44","author":"Bazan","year":"2011","journal-title":"Mol Neurobiol."},{"key":"10.1016\/j.rbp.2012.07.002_bib0430","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.nutr.012809.104635","article-title":"Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases","volume":"31","author":"Bazan","year":"2011","journal-title":"Annu Rev Nutr."},{"issue":"1\u20134","key":"10.1016\/j.rbp.2012.07.002_bib0435","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.prostaglandins.2011.06.003","article-title":"Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission","volume":"96","author":"Rapoport","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"9","key":"10.1016\/j.rbp.2012.07.002_bib0440","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2967\/jnumed.107.049619","article-title":"Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET","volume":"49","author":"Esposito","year":"2008","journal-title":"J Nucl Med."},{"issue":"1 Suppl","key":"10.1016\/j.rbp.2012.07.002_bib0445","doi-asserted-by":"crossref","first-page":"179S","DOI":"10.1093\/ajcn\/71.1.179S","article-title":"Polyunsaturated fatty acids in the food chain in the United States","volume":"71","author":"Kris-Etherton","year":"2000","journal-title":"Am J Clin Nutr."},{"issue":"7","key":"10.1016\/j.rbp.2012.07.002_bib0450","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1194\/jlr.M800530-JLR200","article-title":"Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography","volume":"50","author":"Umhau","year":"2009","journal-title":"J Lipid Res."},{"issue":"12","key":"10.1016\/j.rbp.2012.07.002_bib0455","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11745-000-0646-3","article-title":"Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment","volume":"35","author":"Conquer","year":"2000","journal-title":"Lipids."},{"issue":"17","key":"10.1016\/j.rbp.2012.07.002_bib0460","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA."},{"issue":"9110","key":"10.1016\/j.rbp.2012.07.002_bib0465","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(05)79168-6","article-title":"Fish consumption and major depression","volume":"351","author":"Hibbeln","year":"1998","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.rbp.2012.07.002_bib0470","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.bmcl.2011.01.100","article-title":"[11C] enzastaurin, the first design and radiosynthesis of a new potential PET agent for imaging of protein kinase C","volume":"21","author":"Wang","year":"2011","journal-title":"Bioorg Med Chem Lett."},{"issue":"7","key":"10.1016\/j.rbp.2012.07.002_bib0475","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cmdc.200900045","article-title":"Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress","volume":"4","author":"Kozikowski","year":"2009","journal-title":"ChemMedChem."},{"issue":"24","key":"10.1016\/j.rbp.2012.07.002_bib0480","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1016\/j.bmc.2010.10.018","article-title":"A novel PET marker for in vivo quantification of myelination","volume":"18","author":"Wu","year":"2010","journal-title":"Bioorg Med Chem."},{"issue":"5","key":"10.1016\/j.rbp.2012.07.002_bib0485","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00702-011-0607-8","article-title":"Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease","volume":"118","author":"Lassmann","year":"2011","journal-title":"J Neural Transm."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.002_bib0490","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bip.21302","article-title":"Hsp70 molecular chaperones and Parkinson's disease","volume":"93","author":"Witt","year":"2010","journal-title":"Biopolymers."},{"issue":"7","key":"10.1016\/j.rbp.2012.07.002_bib0495","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","article-title":"Aggresomes: a cellular response to misfolded proteins","volume":"143","author":"Johnston","year":"1998","journal-title":"J Cell Biol."},{"issue":"21","key":"10.1016\/j.rbp.2012.07.002_bib0500","doi-asserted-by":"crossref","first-page":"17471","DOI":"10.1074\/jbc.M112.352781","article-title":"and Z Are Critical in Degrading Polyglutamine- containing Proteins within Lysosomes","volume":"287","author":"Bhutani","year":"2012","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0505","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2310\/7290.2011.00028","article-title":"Monitoring the induction of heat shock factor 1\/heat shock protein 70 expression following 17-allylamino- demethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging","volume":"11","author":"Doubrovin","year":"2012","journal-title":"Mol Imaging."},{"key":"10.1016\/j.rbp.2012.07.002_bib0510","doi-asserted-by":"crossref","unstructured":"Michaud J-P, Richard KL, Rivest S. Hematopoietic MyD88-adaptor Protein Acts as a Natural Defense Mechanism for Cognitive Deficits in Alzheimer's Disease. Stem Cell Rev [Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22374079]. 2012.[cited 2012 May 17].","DOI":"10.1007\/s12015-012-9356-9"},{"issue":"6","key":"10.1016\/j.rbp.2012.07.002_bib0515","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbi.2011.02.017","article-title":"The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity","volume":"25","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.rbp.2012.07.002_bib0520","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1742-2094-8-137","article-title":"The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration","volume":"8","author":"Drouin-Ouellet","year":"2011","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.rbp.2012.07.002_bib0525","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/B978-0-12-385883-2.00005-9","article-title":"Biology of mitochondria in neurodegenerative diseases","volume":"107","author":"Martin","year":"2012","journal-title":"Prog Mol Biol Transl Sci."},{"issue":"5","key":"10.1016\/j.rbp.2012.07.002_bib0530","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"Ray","year":"2012","journal-title":"Cell Signal."},{"key":"10.1016\/j.rbp.2012.07.002_bib0535","doi-asserted-by":"crossref","unstructured":"Kurihara H, Honda N, Kono Y, Arai Y. Radiolabelled Agents for PET Imaging of Tumor Hypoxia. Curr Med Chem [Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22664246]. 2012.[cited 2012 Jun 11].","DOI":"10.2174\/092986712801215964"},{"issue":"7","key":"10.1016\/j.rbp.2012.07.002_bib0540","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nucmedbio.2011.02.016","article-title":"Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET","volume":"38","author":"Ikawa","year":"2011","journal-title":"Nucl Med Biol."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.002_bib0545","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nucmedbio.2011.08.008","article-title":"Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less \u03c10 cells and cybrids carrying MELAS mitochondrial DNA mutation","volume":"39","author":"Yoshii","year":"2012","journal-title":"Nucl Med Biol."},{"issue":"5","key":"10.1016\/j.rbp.2012.07.002_bib0550","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00008571-200305000-00004","article-title":"Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease","volume":"13","author":"Dro\u017adzik","year":"2003","journal-title":"Pharmacogenetics."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.002_bib0555","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood-brain barrier dysfunction in parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann Neurol."},{"issue":"7","key":"10.1016\/j.rbp.2012.07.002_bib0560","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","article-title":"Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans","volume":"12","author":"Vogelgesang","year":"2002","journal-title":"Pharmacogenetics."},{"issue":"11","key":"10.1016\/j.rbp.2012.07.002_bib0565","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","article-title":"Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration","volume":"30","author":"Bartels","year":"2009","journal-title":"Neurobiol Aging."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.002_bib0570","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nucmedbio.2004.06.007","article-title":"Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat","volume":"32","author":"Luurtsema","year":"2005","journal-title":"Nucl Med Biol."},{"issue":"3\u20134","key":"10.1016\/j.rbp.2012.07.002_bib0575","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/prca.201100068","article-title":"Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease","volume":"6","author":"Donovan","year":"2012","journal-title":"Proteomics Clin Appl."},{"issue":"21","key":"10.1016\/j.rbp.2012.07.002_bib0580","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha- synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J Neurosci."},{"key":"10.1016\/j.rbp.2012.07.002_bib0585","doi-asserted-by":"crossref","unstructured":"Zetterberg H, Blennow K. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come? J Alzheimers Dis [Available at: ht**tp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22710917]. 2012.[cited 2012 Jun 22].","DOI":"10.3233\/978-1-61499-154-0-361"}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516444612000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516444612000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T21:30:39Z","timestamp":1745962239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1516444612000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":117,"alternative-id":["S1516444612000256"],"URL":"https:\/\/doi.org\/10.1016\/j.rbp.2012.07.002","relation":{},"ISSN":["1516-4446"],"issn-type":[{"value":"1516-4446","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}